1. Introduction {#sec0005}
===============

Blue Rubber Bleb Nevus Syndrome (BRBNS) is an extremely rare condition, characterized by multifocal venous malformation, reported in approximately 200 cases worldwide [@bib0005], [@bib0010], [@bib0015]. These lesions may present at birth but are more common during childhood and adolescence [@bib0020], [@bib0025]. Most cases are sporadic, although some reports suggest an autosomal dominant transmission [@bib0005], [@bib0030].

BRBNS usually manifests with chronic bleeding [@bib0010], [@bib0015]. There are several treatment options including conservative, endoscopic and surgical [@bib0020], [@bib0035], [@bib0040]. Rarely, complications such as intestinal intussusception may occur and demand surgical evaluation. Despite optimal management, patients are at risk for postoperative complications, including thrombocytopenia and disseminated intravascular coagulation (DIVC) [@bib0045].

We describe a unique case of a pregnant woman, previously diagnosed with BRBNS, who developed intestinal acute abdominal obstruction due to intussusception and postoperative DIVC. This work is being reported in line with the SCARE criteria [@bib0050].

2. Case presentation {#sec0010}
====================

Twenty-five year-old female pregnant patient with prior diagnosis of Blue Rubber Bleb Nevus Syndrome and chronic intestinal bleeding presented with acute onset of colic pain and vomit. Ultrasound showed signs of oligohydramnios and a decision was made for early C-section. Symptoms persisted and a general surgery consult was requested.

Multiple bluish-colored lesions in face, neck, torso and extremities were present ([Fig. 1](#fig0005){ref-type="fig"}). Patient was pale but had no signs of shock. Abdomen was distended and diffusely tender, but signs of peritonitis were absent. Rectal exam was normal.Fig. 1Multiple hemangioma-like lesions may be seen in head, neck, thorax and upper extremities (antecubital fossa and hand).Fig. 1

Computerized Tomography of the abdomen and pelvis showed multiple gastrointestinal lesions compatible with history of hemangiomas, and two jejunal segments exhibiting the target-sign with proximal bowel distension ([Fig. 2](#fig0010){ref-type="fig"}). Previous gastrointestinal endoscopic studies showed multiple hemangiomas throughout the small and large bowels.Fig. 2Computerized Tomography of the abdomen showing a typical target-sign image associated with intestinal intussusception close to the midline.Fig. 2

Videolaparoscopy was initially performed. The surgical team decided for early conversion to laparotomy, due to the risk of bleeding, confirming intussusception ([Fig. 3](#fig0015){ref-type="fig"}). Multiple hemangioma-like lesions were observed on small and large bowel. Liver also had similar polypoid lesions and a large one on the left lobe ([Fig. 4](#fig0020){ref-type="fig"}). After midline small laparotomy, simple reduction of the intussusception segments was performed. A hemangioma-like lesion was the lead point in both. No bleeding was observed at the end of the operation and the patient was sent to the ICU for close monitoring.Fig. 3Multiple hemangioma-like lesions throughout the small bowel and one of the intussuscepted segments.Fig. 3Fig. 4Large polipoid soft lesion on the left liver lobe partially shown in this image.Fig. 4

On the second postoperative day she was tachycardic and distended. Laboratory analysis showed decreased levels of hemoglobin, platelets and fibrinogen, and elevated levels of activated partial thromboplastin time (aPTT) and prothrombin time (PT). CT scan of the abdomen displayed a large intra abdominal clot ([Fig. 5](#fig0025){ref-type="fig"}). This clinical scenario suggested a postoperative disseminated intravascular coagulation (DIVC) secondary to retained clot syndrome. Despite adequate supportive therapy with blood products, she underwent reoperation. A serosal escharification was found on the small bowel, close to the clot, which was evacuated ([Fig. 6](#fig0030){ref-type="fig"}). The patient exhibited normalization of the coagulation status and recovered uneventfully on the following days. She is now being followed in the outpatient clinic and treated with Sirolimus 1 mg twice per day. After one year of follow-up, her basal hemoglobin level went from 5.5 to 11 mg/dl. Her twice-a-week blood transfusion requirement was no longer needed and the size of her lesions also decreased.Fig. 5Computerized Tomography of the pelvis showing hyperattenuating image (arrow) and free fluid compatible with pelvic clot and hemoperitoneum.Fig. 5Fig. 6Serosal escharification on a segment of the small bowel (a) resulting in retained clot (b) syndrome and DIVC.Fig. 6

3. Discussion {#sec0015}
=============

Blue Rubber Blebs Nevus Syndrome (BRBNS) is a rare disease. It's estimated incidence is 1:14.000 births [@bib0055]. The first description of the disease occurred in 1860 by Gascoyen, but the term "Blue Rubber Bleb Nevus Syndrome" was coined by Bean in 1958. This author also described the disease in detail, giving rise to the eponym "Bean Syndrome" [@bib0005], [@bib0015], [@bib0045], [@bib0055]. Epidemiological data show no gender predilection and rare incidence in Blacks [@bib0015], [@bib0045]. In a recent literature review by Jin et al., the onset of the disease could be outlined in 82 patients. About 30% of these patients showed signs of the disease upon birth, 9% during infancy, 48% in childhood, 9% while adolescents and only 4% in adulthood [@bib0015]. These lesions tend to grow in number and in size with increasing age [@bib0060]. Malignant transformation seems rare. It has not been described in GI lesions [@bib0035], [@bib0045], [@bib0060]. However, there is one report of that occurrence in a cutaneous lesion [@bib0035].

Despite recent studies, the pathogenesis of this syndrome is still not fully understood. Although majorly sporadic, several familial cases are associated with chromosome 9p [@bib0015], [@bib0020], [@bib0035], [@bib0040]. Some observations of c-kit in histological analysis suggest that the stem cell factor/c-kit signaling might play a role in the development of the lesions [@bib0015]. The mammalian target of rapamycin (mTOR) complex might also be involved. These protein complexes are related to several cellular processes such as growth, motility, survival. Moreover, vascular endothelial growth factor (VEGF) acts as an upstream stimulator of mTOR signaling pathway promoting angiogenesis [@bib0030].

Clinical presentation was described by Bean in 1958 as a triad: bluish vascular nevi of the skin, hemangioma of the gut, and GI bleeding [@bib0065]. These vascular malformations may occur in virtually any tissue, such as central nervous system, kidney, lungs, spleen, thyroid, bladder [@bib0015], [@bib0020], [@bib0045]. However, they are more common in GI tract, skin and soft tissues [@bib0005], [@bib0010], [@bib0030]. Cutaneous lesions were described as three types: soft bluish bleb-like lesions that quickly refill when pressure is relieved; deforming large lesions that can compress adjacent structures; and macular irregularly blue-stained lesions [@bib0055]. However, usually, cutaneous lesions measure from 1 to 2 centimeters, are asymptomatic, and can vary from several to more than one hundred throughout the body surface [@bib0005], [@bib0010], [@bib0015].

The most common symptoms are GI hemorrhage and iron deficiency anemia (IDA), which result from chronic bleeding from GI lesions and sometimes demand lifelong iron replacement and several blood transfusions [@bib0005], [@bib0015]. Rarely, complications such as intussusception, rupture, intestinal torsion and infarction may develop, prompting emergency evaluation [@bib0005], [@bib0020], [@bib0035], [@bib0040]. Other manifestations such as DIVC and thrombocytopenia have been described [@bib0015], [@bib0045]. It is reported that large extremities lesions may present with deformities and angiomatous gigantism which sometimes require plastic surgery or even amputation of the limb [@bib0020]. Our patient needed weekly transfusions and daily iron replacement. She developed both obstructive and coagulation complications during hospital stay.

Diagnosis is based on clinical findings. Typical skin lesions as already described are easily noted upon inspection. Endoscopic evaluation of the GI tract by esophagogastroduodenoscopy, enteroscopy and colonoscopy, may support the diagnosis [@bib0010]. Moreover, non-invasive tools such as capsule endoscopy, ultrasound, computed tomography or magnetic resonance are also useful to clarify the diagnosis [@bib0015], [@bib0035]. Histologically, these lesions show cavernous venous dilatations and a single layer of endothelial cells. The presence of smooth muscle and fibrous tissue vary according to the size of the vascular channels [@bib0015], [@bib0060]. Differential diagnosis of cutaneous and GI tract hemangiomatosis include Maffucci, Osler-Weber-Rendu, Klippel-Trenaunay-Weber, Hippel-Lindau, Sturge-Weber and Louis-Bar syndromes [@bib0015], [@bib0020], [@bib0035]

Management of BRBNS lacks consensus. Literature is scarce and based mainly in case reports. Hence, it must be individualized according to the severity of the symptoms. All patients exhibiting mild anemia should be treated with conservative measures such as iron supplementation, blood transfusion and nutritional support [@bib0020]. Antiangiogenic agents, interferon and octreotide have been used to control the bleeding of the lesions, however there is no robust evidence of their long-term efficacy in BRBNS [@bib0005], [@bib0010], [@bib0030]. A myriad of endoscopic treatments were described such as laser photocoagulation, resection, band ligation, electrocauterization, plasma argon coagulation and histoacryl injection. However, there is little evidence to support long-term benefit of such therapies and some authors suggest a potential risk of perforation and rebleeding [@bib0005], [@bib0030], [@bib0035].

The role of surgical excision is highly dependant on symptoms and extent of the disease. Full diagnostic GI tract workup is mandatory for accurate surgical planning [@bib0005], [@bib0010]. For patients with small number of lesions, surgery can provide symptomatic remission and better quality of life. However, massive involvement, as in our patient, should alert the surgeon about potential inoperability and consideration for alternative therapies [@bib0015], [@bib0020], [@bib0040]. Some authors highlight the risk of short gut syndrome in extensive resections, and recurrence [@bib0040], [@bib0045]. For overt hemorrhages or complications such as torsion, intussusception or rupture, operative intervention is mandatory and resection of the affected segment may be required [@bib0015], [@bib0025], [@bib0035], [@bib0070].

Sirolimus, also known as rapamycin, exerts an antiangiogenic effect by blocking m-TOR signaling pathways and decreasing both production and target-cell stimulation by VEGF [@bib0075]. This drug was first introduced for treatment of BRBNS by Yuksekkaya et al. in case report, yielding good results [@bib0030].

Postoperative complications in patients with BRBNS are rarely reported. DIVC is mostly related to infection, malignancy, and trauma, although other conditions might be accounted for this coagulation disorder [@bib0080]. In our case, our hypothesis was that bleeding from the serosal escharification and clot formation, along with her underlying condition and pregnancy, might have led to DIVC. Hence, besides supportive therapy, we performed clot evacuation resulting in normalization of her acute DIVC.

In addition to the rare presentation of intussusception, this is the first case, to our knowledge, of postoperative DIVC in a BRBNS patient, which was successfully treated with clot evacuation and hemostasis (Clavien 3b postoperative complication). This report aims to increase awareness of this morbid condition and of the potentially life-threatening complications associated with this disease and it́s management.

4. Conclusion {#sec0020}
=============

We describe a rare case of a pregnant patient presenting to the emergency surgical department with a complication of BRBNS represented by intestinal intussusception. This is the first case of postoperative DIVC in a patient with BRBNS, which was successfully treated. Clinicians should be familiar with this rare condition, it́s clinical manifestations and management, and the potential complications. Accurate diagnosis and therapy are mandatory for a good outcome.
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